AU2002232558A1 - Compounds, compositions and methods for treatment of parasitic infections - Google Patents

Compounds, compositions and methods for treatment of parasitic infections

Info

Publication number
AU2002232558A1
AU2002232558A1 AU2002232558A AU3255802A AU2002232558A1 AU 2002232558 A1 AU2002232558 A1 AU 2002232558A1 AU 2002232558 A AU2002232558 A AU 2002232558A AU 3255802 A AU3255802 A AU 3255802A AU 2002232558 A1 AU2002232558 A1 AU 2002232558A1
Authority
AU
Australia
Prior art keywords
compositions
compounds
treatment
methods
parasitic infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232558A
Inventor
Gian L. Araldi
Erick A. Goldman
Marguerita Lim-Wilby
Joseph Edward Semple
Michael I. Weinhouse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Pharmaceuticals LLC
Original Assignee
Corvas International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corvas International Inc filed Critical Corvas International Inc
Publication of AU2002232558A1 publication Critical patent/AU2002232558A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002232558A 2000-12-12 2001-12-11 Compounds, compositions and methods for treatment of parasitic infections Abandoned AU2002232558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25522100P 2000-12-12 2000-12-12
US60/255,221 2000-12-12
PCT/US2001/048032 WO2002048097A1 (en) 2000-12-12 2001-12-11 Compounds, compositions and methods for treatment of parasitic infections

Publications (1)

Publication Number Publication Date
AU2002232558A1 true AU2002232558A1 (en) 2002-06-24

Family

ID=22967366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232558A Abandoned AU2002232558A1 (en) 2000-12-12 2001-12-11 Compounds, compositions and methods for treatment of parasitic infections

Country Status (3)

Country Link
US (1) US20020107266A1 (en)
AU (1) AU2002232558A1 (en)
WO (1) WO2002048097A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180550A1 (en) 1999-04-19 2002-07-30 Smithkline Beecham Corp FAB I INHIBITORS
CO5370679A1 (en) 1999-06-01 2004-02-27 Smithkline Beecham Corp FAB INHIBITORS 1
PE20010635A1 (en) 1999-10-08 2001-08-15 Smithkline Beecham Corp USEFUL FAB I INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
US7700341B2 (en) 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
AU2002305052A1 (en) 2001-03-13 2002-09-24 Corvas International, Inc. Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
JP2004535166A (en) 2001-03-22 2004-11-25 デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー Nucleic acid molecule encoding serine protease CVSP14, encoded polypeptide and methods based thereon
NZ527971A (en) 2001-03-27 2006-03-31 Dendreon Corp Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
ES2320984T3 (en) 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. FAB INHIBITORS I.
WO2002092841A2 (en) 2001-05-14 2002-11-21 Dendreon San Diego Llc Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
BRPI0503951A (en) * 2005-07-15 2007-03-06 Fundacao De Amparo A Pesquisa process of obtaining synthetic and semi-synthetic derivatives of lignans, their antiparasitic activities and their pharmaceutical formulations, encompassing the therapeutic method using such lignans in the treatment of parasitic diseases.
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
US8263613B2 (en) 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
UY32827A (en) * 2009-08-12 2011-02-28 Glaxo Group Ltd CATEPSIN C INHIBITORS
CN103491777B (en) * 2011-02-11 2015-05-06 葛兰素史密斯克莱知识产权发展有限公司 Cathepsin c inhibitors
NZ702695A (en) 2012-06-19 2015-10-30 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
WO2017137448A1 (en) 2016-02-10 2017-08-17 Axiava Pharma Ug Dipeptidyl aldehydes for the treatment and/or prevention of parasitic diseases
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
WO2023165334A1 (en) * 2022-03-01 2023-09-07 成都威斯克生物医药有限公司 Keto amide derivatives and pharmaceutical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112759A0 (en) * 1994-02-25 1995-05-26 Khepri Pharmaceuticals Inc Novel cysteine protease inhibitors
EP0817778A1 (en) * 1995-03-24 1998-01-14 Arris Pharmaceutical Corporation Reversible protease inhibitors
ES2293651T3 (en) * 1995-11-28 2008-03-16 Cephalon, Inc. INHIBITORS OF CYSTEINE AND SERINE PROTEASES DERIVED FROM AMINO ACIDS D.
US6150378A (en) * 1997-10-07 2000-11-21 Cephalon, Inc. Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
JP2002539190A (en) * 1999-03-15 2002-11-19 アクシス・ファーマシューティカルズ・インコーポレイテッド Novel compounds and compositions as protease inhibitors

Also Published As

Publication number Publication date
WO2002048097A1 (en) 2002-06-20
WO2002048097B1 (en) 2003-02-20
US20020107266A1 (en) 2002-08-08
WO2002048097A9 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
GB0125222D0 (en) Composition for the treatment of microbial infections
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2002329884A1 (en) Processed soft tissue for topical or internal application
AU2001233081A1 (en) Composition for treatment of stress
AU2001272852A1 (en) Composition for the treatment of migraine
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2001286983A1 (en) Method of treatment
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2003296963A1 (en) Methods and compositions for treating and preventing ear infections
AU2003239132A1 (en) Methods and compositions for preventing and treating microbial infections
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2002365083A1 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
AU2002334761A1 (en) Methods of treating drug-resistant bacterial infections
AU2003237088A1 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU2002302580A1 (en) Use of phyllanthus constituents for treating or preventing infections caused by hepatit
AU2002242096A1 (en) Novel compounds and methods for inhibiting/treating hiv infections and aids related symptoms
AU2001262177A1 (en) Method of treatment
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2001258675A1 (en) Treating infections